Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
CPT Pharmacometrics Syst Pharmacol
.
2023 Nov;12(11):1569-1572.
doi: 10.1002/psp4.13066.
Epub 2023 Nov 3.
Authors
Priya Jayachandran
1
,
Rajat Desikan
2
,
Sriram Krishnaswami
3
,
Stefanie Hennig
4
5
Affiliations
1
Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
2
Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline (GSK), Stevenage, Hertfordshire, UK.
3
Oncology Research and Development, Pfizer, Groton, Connecticut, USA.
4
Certara, Inc., Melbourne, Victoria, Australia.
5
School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
PMID:
37849052
PMCID:
PMC10681474
DOI:
10.1002/psp4.13066
No abstract available
Publication types
Editorial
MeSH terms
Humans
Medical Oncology
Network Pharmacology
Pharmacology*
Pharmacology, Clinical*